SCHEMBL6027022

SCHEMBL6027022

C[S+]([O-])CCN1CC(c2cccc(F)c2F)CCC(N)C1=O

nearest known ligand 0.41

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CALCRL Q16602 20/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1198427 1.00 CALCRL (0.41) CALCRL
SCHEMBL13798878 0.85 CALCRL (0.47) CALCRL
SCHEMBL13929777 0.84 CALCRL (0.48) CALCRL
SCHEMBL1198278 0.84 CALCRL (0.46) CALCRL
SCHEMBL1198467 0.83 CALCRL (0.49) CALCRL
SCHEMBL1198384 0.83 CALCRL (0.49) CALCRL
SCHEMBL5815838 0.83 CALCRL (0.49) CALCRL
SCHEMBL1197405 0.83 CALCRL (0.50) CALCRL
SCHEMBL2896515 0.83 CALCRL (0.52) CALCRL
SCHEMBL2767146 0.80 CALCRL (0.44) CALCRL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1638969-A2 CGRP RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2006-03-29 — — EP disclosed
WO-2004092166-A2 CGRP RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2004-10-28 — — WO disclosed
Send feedback